id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-0030-8507,FDA,FDA-2015-N-0030,Memorandum of Meeting from FDA/CDER,Other,Memorandum,2021-12-01T05:00:00Z,2021,12,2021-12-01T05:00:00Z,,2021-12-01T21:02:19Z,,0,0,0900006484e8cda7
FDA-2015-N-0030-8506,FDA,FDA-2015-N-0030,Extension of the Period Before the Food and Drug Administration Intends To Begin Enforcing the Statutory 5 Percent Limit on Out of State Distribution of Compounded Human Drug Products,Notice,Extension of Compliance Date,2021-08-09T04:00:00Z,2021,8,2021-08-09T04:00:00Z,,2021-08-09T13:10:59Z,2021-16937,0,0,0900006484c365db